Review articlePublished 2018
What about Treatment of Metastatic Bladder Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Bladder cancer is the most common malignancy of urinary tract with high rate of morbidity and mortality. Platinum-based chemotherapy remains the first line treatment of advanced disease. Despite several studies, the place of targeted therapies is not yet defined, whereas immunotherapy is currently the standard of care in second-line treatment. Materials and methods: A comprehensive search of MEDLINE/Pubmed and Embase was conducted to identify conference abstracts, basic science, original and review articles in English. Conclusion: This review of the literature will discuss the molecular mechanisms involved in tumor progression, the current management of metastatic bladder cancer and future potential treatment modalities.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Adil Debbagh”
- BylineArticles whose byline prints “Khaoula Alaoui Slimani”
- BylineArticles whose byline prints “Yassir Sbitti”
- BylineArticles whose byline prints “Hassan Errihani”
- BylineArticles whose byline prints “Mohammed Ichou”
